MedTrace Logo

Screening for Metabolic Problems in Mothers of Children With Autism and Typically Developing Children

NCT02674022 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2020-10-19

No results posted yet for this study

Summary

The purpose of this research study is to screen for metabolic abnormalities that are maternal risk factors for having a child with autism.

Conditions

  • Pregnancy
  • Autistic Disorder
  • Folic Acid Deficiency

Interventions

DIETARY_SUPPLEMENT

Prenatal supplement

Treatment with a standard and optimized prenatal supplement, dependent on laboratory evaluations of participants.

Sponsors & Collaborators

  • Arizona State University

    collaborator OTHER

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Bryan Woodruff, MD · Mayo Clinic

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-20
Primary Completion
2018-04-05
Completion
2018-04-05

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02674022 on ClinicalTrials.gov